-検索条件
-検索結果
検索 (著者・登録者: kuroda & n)の結果全48件を表示しています

EMDB-65634: 
Cryo-EM structure of Enterovirus-D68 MO strain virus-like particle
手法: 単粒子 / : Senpuku K, Hirose M, Ito T, Kato T, Yshioka Y

PDB-9w4i: 
Cryo-EM structure of Enterovirus-D68 MO strain virus-like particle
手法: 単粒子 / : Senpuku K, Hirose M, Ito T, Kato T, Yshioka Y

EMDB-61204: 
Cryo-EM Structure of calcium sensing receptor in complex gamma-glutamyl-valyl-glycine as a kokumi substance
手法: 単粒子 / : Yamaguchi H, Kitajima S, Suzuki H, Suzuki S, Nishikawa K, Maruyama Y, Kamegawa A, Kazutoshi T, Tagami U, Kuroda M, Fujiyoshi Y, Sugiki M

PDB-9j7i: 
Cryo-EM Structure of calcium sensing receptor in complex gamma-glutamyl-valyl-glycine as a kokumi substance
手法: 単粒子 / : Yamaguchi H, Kitajima S, Suzuki H, Suzuki S, Nishikawa K, Maruyama Y, Kamegawa A, Kazutoshi T, Tagami U, Kuroda M, Fujiyoshi Y, Sugiki M

EMDB-37910: 
Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38459: 
Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38686: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38687: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38688: 
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38689: 
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-38690: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-60886: 
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-60904: 
Structure of SARS-CoV-2 JN.1 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-60905: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (1 highly-open RBD and 1 partially-open RBD)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-60906: 
Structure of SARS-CoV-2 JN.1 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8wxl: 
Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xux: 
Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xuy: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xuz: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xv0: 
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xv1: 
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-8xvm: 
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

PDB-9iu1: 
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T

EMDB-34741: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34742: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgl: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgm: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34429: 
Cryo-EM structure of KpFtsZ-monobody double helical tube
手法: らせん対称 / : Fujita J, Amesaka H, Yoshizawa T, Kuroda N, Kamimura N, Hara M, Inoue T, Namba K, Tanaka S, Matsumura H

EMDB-35344: 
Cryo-EM structure of KpFtsZ single filament
手法: らせん対称 / : Fujita J, Amesaka H, Yoshizawa T, Kuroda N, Kamimura N, Hibino K, Konishi T, Kato Y, Hara M, Inoue T, Namba K, Tanaka S, Matsumura H

PDB-8h1o: 
Cryo-EM structure of KpFtsZ-monobody double helical tube
手法: らせん対称 / : Fujita J, Amesaka H, Yoshizawa T, Kuroda N, Kamimura N, Hara M, Inoue T, Namba K, Tanaka S, Matsumura H

PDB-8ibn: 
Cryo-EM structure of KpFtsZ single filament
手法: らせん対称 / : Fujita J, Amesaka H, Yoshizawa T, Kuroda N, Kamimura N, Hibino K, Konishi T, Kato Y, Hara M, Inoue T, Namba K, Tanaka S, Matsumura H

EMDB-33820: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33821: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33822: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33823: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33824: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33825: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33826: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33827: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33828: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33829: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33830: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh6: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh7: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-27112: 
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (global refinement)
手法: 単粒子 / : Ozorowski G, Torres JL, Turner HL, Ward AB

EMDB-27113: 
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
手法: 単粒子 / : Ozorowski G, Torres JL, Turner HL, Ward AB

PDB-8d0z: 
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
手法: 単粒子 / : Ozorowski G, Torres JL, Ward AB

EMDB-30070: 
Nucleosome with LIN28B distal enhancer DNA sequence
手法: 単粒子 / : Echigoya K, Koyama M, Takizawa Y, Kurumizaka H
ムービー
コントローラー
構造ビューア
EMN検索について



wwPDBはEMDBデータモデルのバージョン3へ移行します
